Inactive Instrument

YM BioSciences Inc. Stock

Equities

Duration

Period

Style

YM Biosciences : Raises US$80.5 Million from Public Offering	12-02-29	PU
YM Biosciences : Prices $70 Million Public Offering of Common Shares	12-02-24	PU
YM Biosciences : Announces Proposed Public Offering of Common Shares	12-02-23	PU
YM Biosciences : Reports Operational and Financial Results for the Second Quarter of Fiscal 2012	12-02-09	PU
YM Biosciences : Reports Updated Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at ASH 2011	11-12-12	PU

Sector

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	-1.78%	41.71B
LONZA GROUP AG	+47.70%	41.56B
MODERNA, INC.	+4.01%	39.74B
CELLTRION, INC.	-15.14%	25.61B
ICON PUBLIC LIMITED COMPANY	+3.16%	24.26B
ALNYLAM PHARMACEUTICALS, INC.	-24.08%	18.55B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-2.67%	11.93B
MEDPACE HOLDINGS, INC.	+24.76%	11.93B
UNITED THERAPEUTICS CORPORATION	+7.01%	10.91B